logo-loader
ASX:PXS

Pharmaxis Ltd

Market:
ASX
Market Cap:
$34.53 m
Price
0.09 AUD
Change
2.35%
52 weeks high
0.29
52 weeks low
0.05

In brief

Pharmaxis Ltd (ASX:PXS) is an Australian pharmaceutical research company with expertise in developing drugs for inflammatory and fibrotic diseases and focussed on myelofibrosis.

Deep dive We explore the investor case for growth companies

Snapshot

The company completed both its phase 1b trial of its systemic pan‐LOX inhibitor and a further phase 1 dosing study of its LOXL2 inhibitor in March.